Characterization of Melanoma Cells Capable of Propagating Tumors from a Single Cell

Por Held, Matthew A., Curley, David P., Dankort, David, McMahon, Martin, Muthusamy, Viswanathan, Bosenberg, Marcus W.
Publicado em 2010

Genotype-Selective Combination Therapies for Melanoma Identified by High Throughput Drug Screening

Por Held, Matthew A., Langdon, Casey G., Platt, James T., Graham-Steed, Tisheeka, Liu, Zongzhi, Chakraborty, Ashok, Bacchiocchi, Antonella, Koo, Andrew, Bosenberg, Marcus W., Stern, David F.
Publicado em 2012

BRAF inhibition decreases cellular glucose uptake in melanoma in association with reduction in cell volume

Por Theodosakis, Nicholas, Held, Matthew A., Marzuka-Alcala, Alexander, Meeth, Katrina M., Micevic, Goran, Long, Georgina V., Scolyer, Richard A., Stern, David F., Bosenberg, Marcus W.
Publicado no Mol Cancer Ther (2015)

The Broad Spectrum Receptor Tyrosine Kinase Inhibitor Dovitinib Suppresses Growth of BRAF Mutant Melanoma Cells in Combination with Other Signaling Pathway Inhibitors

Por Langdon, Casey G., Held, Matthew A., Platt, James T., Meeth, Katrina, Iyidogan, Pinar, Mamillapalli, Ramanaiah, Koo, Andrew B., Klein, Michael, Liu, Zongzhi, Bosenberg, Marcus W., Stern, David F.
Publicado no Pigment Cell Melanoma Res (2015)

SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells

Por Langdon, Casey G., Wiedemann, Norbert, Held, Matthew A., Mamillapalli, Ramanaiah, Iyidogan, Pinar, Theodosakis, Nicholas, Platt, James T., Levy, Frederic, Vuagniaux, Gregoire, Wang, Shaomeng, Bosenberg, Marcus W., Stern, David F.
Publicado no Oncotarget (2015)